Spotlighting Lessons Learned to Advance ADC Development Through Preclinical Models

• Understanding the rationale behind selecting the tumour models that were employed to aid the development of ADCs
• Overcoming the challenges with uncovering the therapeutic potential of the candidate to ensuring its effective translation to the clinic

Speakers:

Ilona Procházková

Scientist

SOTIO Biotech a.s.